What is MariTide and how does it work? Official answer: MariTide (maridebart cafraglutide) is an investigational once-monthly injection that blocks the glucose-dependent...

What is MariTide - new weight loss drug -> www.drugs.com/medical-answ... #weightloss #maritide #amgen #medications #pharmacist #pharmD

Monthly Obesity Shot, MariTide, Shows Big Weight Loss in Trial - Drugs.com MedNews WEDNESDAY, June 25, 2025 Alternatives to weekly injections of weight-loss drugs may on the way. A monthly dose of a new drug called MariTide helped participants

Experimental weight-loss drug #MariTide shows promise with monthly injections. Phase 2 trial participants lost 20% body weight. Still in testing, not available yet. www.drugs.com/news/monthly...

Once-monthly obesity injection shows double-digit weight loss in major clinical trial Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in adults with obesity, with or without diabetes, in a phase 2 randomized trial...

Once-monthly obesity injection shows double-digit weight loss in major clinical trial www.news-medical.net/news/2025062... #MariTide #obesity #weightloss #maridebart #cafraglutide #diabetes #innovation #health #pharma #research #GLP1 @nejm.org

ADA2025: Two Remarkable New Obesity Drugs at an Early Stage - ConscienHealth On the closing day of ADA2025, two new obesity drugs, MariTide and bimagrumab stole the show with promising phase two clinical results.

At #ADA2025 the treat of the day was a good look at intriguing results from two very promising new and unique #ObesityMedicines, #MariTide and #bimagrumab.
HT: @amgen.bsky.social @elilillyandcompany.bsky.social
conscienhealth.org/2025/06/ada2...

Amgen Unveils Promising Results from Phase 2 Study of MariTide for Obesity Treatment Amgen has revealed significant outcomes from its Phase 2 trial of MariTide, showcasing potential for substantial weight loss and health improvements in obesity treatment.

Amgen Unveils Promising Results from Phase 2 Study of MariTide for Obesity Treatment #United_States #California #MariTide #Amgen #Obesity_Treatment

Amgen's Phase 2 MariTide Data to be Unveiled at ADA's 85th Scientific Sessions Amgen will present promising Phase 2 study data for MariTide at the ADA 85th Scientific Sessions, showcasing its potential for obesity and Type 2 diabetes treatment.

Amgen's Phase 2 MariTide Data to be Unveiled at ADA's 85th Scientific Sessions #United_States #Chicago #MariTide #Amgen #Type_2_Diabetes

The weight-loss drugs being tested in 2025: will they beat Ozempic? Drug companies are trialling a host of medications that they hope will offer benefits beyond weight loss.

New weight-loss drugs in trials for 2025 are hoping to beat Ozempic!
Treatments like #Tirzepatide to #Retatrutide & #MariTide target weight loss, heart health & muscle preservation.
Oral options like #Orforglipron could be a game changer.

Read more here: www.nature.com/articles/d41...

It's tough being different. People get twitchy – just as investors did yesterday when @amgen.bsky.social released phase 2 results for #MariTide in #obesity. This unique drug has the potential for great benefits and thus comes with risks. Time will tell.
conscienhealth.org/2024/11/twit...

Given dosing advantage, Amgen drug may not need best-in-class weight loss Key Phase II data from Amgen’s most valuable clinical candidate, obesity molecule MariTide, showed that the biotech may have a competitive advantage...

My take on the #MariTide data: #tirzepatide -like efficacy with once-monthly dosing and potential for a quarterly maintenance dose, and potential to more easily supply the market with lower peptide required? Sounds like a competitive commercial profile to me $AMGN www.biocentury.com/article/654323

Amgen's New Weight Loss Treatment MariTide Shows Promise in Phase 2 Study for Obesity Management Amgen's MariTide has exhibited significant weight loss results over 52 weeks in individuals with obesity, paving the way for potential new obesity treatments.

Amgen's New Weight Loss Treatment MariTide Shows Promise in Phase 2 Study for Obesity Management #United_States #MariTide #Amgen #obesity #Thousand_Oaks